--- title: "Perfusion Tech ApS – CVR 38238213, financials and ownership" description: "Perfusion Tech ApS (CVR 38238213): PerfusionTech is a Copenhagen-based MedTech company established in 2016 that develops and markets image analysis software for intrasurgical perfusion quantification and visualization." canonical_url: "https://datapublica.dk/en/companies/38238213-perfusion-tech-aps" locale: "en" route_type: "company_overview" robots: "index,follow" --- # Perfusion Tech ApS Perfusion Tech ApS \(CVR 38238213\): PerfusionTech is a Copenhagen-based MedTech company established in 2016 that develops and markets image analysis software for intrasurgical perfusion quantification and visualization. CVR number: 38238213 ## Company details - **CVR number:** 38238213 - **Status:** Aktiv - **Address:** Viborggade 70D 1, 2100, København Ø - **Legal form:** Anpartsselskab \(ApS\) - **Founded:** Nov 28, 2016 - **Employees / FTEs:** 6 / 6 - **Production units:** 1 - **Website:** https://perfusiontech.com/ ## Description PerfusionTech is a Copenhagen-based MedTech company established in 2016 that develops and markets image analysis software for intrasurgical perfusion quantification and visualization. PerfusionTech develops and markets software for real-time quantification and visualization of tissue perfusion during surgery, including blood vessel mapping. ### Company's own description on virk.dk The Company's purpose is to develop, market and commercialize medical devices, including carrying out research and development activities and other related activities. ### Products & services PerfusionWorks software for real-time perfusion quantification • PerfusionWorks software for blood vessel mapping • Intrasurgical image analysis software • Real-time tissue perfusion quantification and visualization • Software for identifying blood vessels during fluorescence imaging ### Industries Healthcare • software\_saas ### Customer types Healthcare professionals • Surgeons ## Activities and industry - Forskning og eksperimentel udvikling inden for naturvidenskab og teknik - 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik ## Latest financial period - **Reporting period:** 2025 - **Currency:** DKK - **Gross profit:** -6,142,804 - **Operating profit:** -14,435,121 - **Profit after tax:** -12,724,708 - **Assets:** 4,586,810 - **Equity:** -9,640,655 ## People No current people or role data available ## Auditor | Audit firm | Auditor | Role | From | | --- | --- | --- | --- | | EY Godkendt Revisionspartnerselskab | Henrik Pungvig Jensen | State Authorised Public Accountant | Jun 9, 2026 | ## Contact ### From [cvr.dk](https://datacvr.virk.dk/) Advertising protected Contact details from CVR must not be used for direct marketing when the entity is advertising protected. The protection does not cover details collected from the company’s own website. The general marketing rules still apply. [Read more at the Danish Business Authority](https://virksomhedsguiden.dk/content/ydelser/faa-reklamebeskyttet-din-virksomhed-i-cvr/3337006d-3b93-4bb0-bc08-82a0915c0332/) | Contact | Phone | Email | | --- | --- | --- | | Company | 4267\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F38238213-perfusion-tech-aps) | co\*\*\*\*\*@perfusiontech.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F38238213-perfusion-tech-aps) | ### From [perfusiontech.com](https://perfusiontech.com/) | Contact | Phone | Email | | --- | --- | --- | | Main | — | co\*\*\*\*\*@perfusiontech.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F38238213-perfusion-tech-aps) | ## Legal owners ### Current | Owner | Ownership | Voting rights | From | | --- | --- | --- | --- | | OwnerRenew Pharmaceuticals Limited | Ownership100 % | Voting rights100 % | FromJun 4, 2025 | ### Previous | Owner | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | OwnerM.T. Lund Holdings ApS | Ownership10–14.99 % | Voting rights10 % | FromDec 12, 2024 | ToJun 4, 2025 | | OwnerMHAaM Holdings ApS | Ownership10–14.99 % | Voting rights10 % | FromDec 12, 2024 | ToJun 4, 2025 | | OwnerQuantass ApS | Ownership5–9.99 % | Voting rights5 % | FromJul 11, 2024 | ToJun 4, 2025 | | OwnerTJ Biotech Holding ApS | Ownership5–9.99 % | Voting rights5 % | FromSep 22, 2023 | ToJun 4, 2025 | | OwnerRenew Pharmaceuticals Limited | Ownership25–33.32 % | Voting rights25 % | FromJul 11, 2024 | ToJun 3, 2025 | | OwnerM.T. Lund Holdings ApS | Ownership15–19.99 % | Voting rights15 % | FromSep 22, 2023 | ToDec 11, 2024 | | OwnerMHAaM Holdings ApS | Ownership15–19.99 % | Voting rights15 % | FromSep 22, 2023 | ToDec 11, 2024 | | OwnerRenew Pharmaceuticals Limited | Ownership15–19.99 % | Voting rights15 % | FromSep 22, 2023 | ToJul 10, 2024 | | OwnerQuantass ApS | Ownership10–14.99 % | Voting rights10 % | FromMar 21, 2022 | ToJul 10, 2024 | | OwnerUddannelses- og Forskningsstyrelsen | Ownership5–9.99 % | Voting rights5 % | FromJul 14, 2023 | ToSep 22, 2023 | | OwnerM.T. Lund Holdings ApS | Ownership20–24.99 % | Voting rights20 % | FromMar 21, 2022 | ToSep 21, 2023 | | OwnerMHAaM Holdings ApS | Ownership20–24.99 % | Voting rights20 % | FromMar 21, 2022 | ToSep 21, 2023 | | OwnerTJ Biotech Holding ApS | Ownership10–14.99 % | Voting rights10 % | FromMar 21, 2022 | ToSep 21, 2023 | | OwnerUddannelses- og Forskningsstyrelsen | Ownership10–14.99 % | Voting rights10 % | FromJan 1, 2019 | ToJul 13, 2023 | | OwnerM.T. Lund Holdings ApS | Ownership25–33.32 % | Voting rights25 % | FromNov 28, 2016 | ToMar 20, 2022 | | OwnerMHAaM Holdings ApS | Ownership25–33.32 % | Voting rights25 % | FromNov 28, 2016 | ToMar 20, 2022 | | OwnerQUANTASS ApS | Ownership10–14.99 % | Voting rights10 % | FromOct 29, 2019 | ToDec 13, 2020 | | OwnerTJ BIOTECH HOLDING ApS | Ownership10–14.99 % | Voting rights10 % | FromOct 29, 2019 | ToDec 13, 2020 | | OwnerQUANTASS ApS | Ownership15–19.99 % | Voting rights15 % | FromNov 28, 2016 | ToOct 28, 2019 | | OwnerTJ BIOTECH HOLDING ApS | Ownership15–19.99 % | Voting rights15 % | FromNov 28, 2016 | ToOct 28, 2019 | | OwnerUddannelses- og Forskningsstyrelsen | Ownership5–9.99 % | Voting rights5 % | FromOct 25, 2017 | ToDec 31, 2018 | | OwnerUddannelses- og Forskningsstyrelsen | Ownership5–9.99 % | Voting rights5 % | FromNov 28, 2016 | ToOct 24, 2017 | | OwnerASBA CONSULTING ApS | Ownership15–19.99 % | Voting rights15 % | FromNov 28, 2016 | ToFeb 28, 2017 | ## Ultimate owners [View ownership diagram](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/portfolio) | Name | Ownership through | Calculated ownership | | --- | --- | --- | | Renew Pharmaceuticals Limited | Direct | 100 % | ## Company pages - [Overview](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps) - [Financial report](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/financials) - [Risk](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/risk) - [Timeline](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/timeline) - [Ownership and relations](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/portfolio) - [Production units](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/production-units) - [Gazelle](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/gazelle) - [Investments](https://datapublica.dk/en/companies/38238213-perfusion-tech-aps/investments) - [Company website](https://perfusiontech.com/) ## Official sources - [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/38238213)